Clinical Trial Update: Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bowel cleansing efficacy of PLENVU vs SELG-ESSE with a 2-day split dosing regimen; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenoma
• Colon Lesion
• Colon Polyp

Drugs mentioned

• Plenvu (Polyethylene glycol-based bowel cleansing solution)
• SELG-ESSE (pharmacological bowel cleanser)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Colon Polyp, Colon Adenoma | Phase 4 | Status: COMPLETED